Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Highly Active Antiretroviral Therapy
100%
Acquired Immune Deficiency Syndrome
100%
Human Immunodeficiency Virus Infection
60%
Immunosuppressive Treatment
40%
Human Immunodeficiency Virus
40%
Cell Count
40%
Rheumatic Disease
40%
Prevalence
20%
Recurrent Disease
20%
Lupus Erythematosus
20%
Disease Activity
20%
Opportunistic Infection
20%
Viremia
20%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
20%
Immunity
20%
Keyphrases
AIDS/HIV
100%
Systemic Lupus Erythematosus
100%
Highly Active Antiretroviral Therapy (HAART)
100%
Human Immunodeficiency Virus Infection
60%
Immunosuppression
40%
CD4 Count
40%
Human Immunodeficiency Virus Patients
40%
Rheumatic Diseases
40%
African American Women
20%
Hispanic Females
20%
Quiescence
20%
Viremia
20%
Older Women
20%
Immune Status
20%
Opportunistic Infections
20%
Transverse Myelitis
20%
Nursing and Health Professions
Systemic Lupus Erythematosus
100%
Acquired Immune Deficiency Syndrome
100%
Highly Active Antiretroviral Therapy
100%
Human Immunodeficiency Virus Infection
60%
Human Immunodeficiency Virus
40%
Immunosuppressive Treatment
40%
CD4 Lymphocyte Count
40%
Rheumatic Disease
40%
Prevalence
20%
Recurrent Disease
20%
Disease Activity
20%
Opportunistic Infection
20%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
20%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Lupus Erythematosus
100%
Acquired Immune Deficiency Syndrome
100%
Human Immunodeficiency Virus Infection
60%
HIV
40%
Rheumatic Disease
40%
Prevalence
20%
Recurrent Disease
20%
Disease Activity
20%
Opportunistic Infection
20%
Viremia
20%
N [bis(1 Aziridinyl)phosphinyl] 4 Iodobenzamide
20%